Sage Journals: Discover world-class research

Retricted access

Review article

First published 2017-1

Crizotinib: Renal Safety Evaluation

Mark A. Perazella, Hassan Izzedine

Journal of Onco-Nephrology

Retricted access

Research article

First published 2013-09

Fishing for ALK with immunohistochemistry may predict response to crizotinib

Mario Bavieri, Marcello Tiseo, Sylvie Lantuejoul [...]

Tumori Journal

Retricted access

Case report

First published 2019-4

Crizotinib-induced erosive esophagitis in a pediatric patient with neuroblastoma

Nicole Lubcke, Kevin Van Camp

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2022-6

Crizotinib for c-MET –amplified advanced NSCLC: a single-center experience

Seher Yildiz Tacar, Mesut Yilmaz, Buge Oz [...]

Tumori Journal

Retricted access

Case report

First published 2015-3

Neoadjuvant Crizotinib in Advanced Inflammatory Myofibroblastic Tumour with ALK Gene Rearrangement

Shereen Rafee, Yasir Y. Elamin, Eimear Joyce [...]

Tumori Journal

Retricted access

Case report

First published 2016-11

Crizotinib Primary Resistance Overcome by Ceritinib in a Patient with ALK-Rearranged Non-Small Cell Lung Cancer

Francesco Facchinetti, Caroline Caramella, Nathalie Auger [...]

Tumori Journal

Open access

Case report

First published 2018

Crizotinib,an Effective Agent in ROS1 -Rearranged Adenocarcinoma of Lungs: A Case Report

Julie Mariam Joshua, Salima KD, Pavithran K [...]

Clinical Medicine Insights: Case Reports

Free access

Review article

First published 2011-11

The potential for crizotinib in non-small cell lung cancer: a perspective review

Yung-Jue Bang

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2020-6

How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature

Ozkan Alan, Okan Kuzhan, Sinan Koca [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2020-3

An advanced c-MET-amplified NSCLC patient that was treated with crizotinib

Mesut Yilmaz, Sermin Guven Mese, Ibrahim Cil [...]

Journal of Oncology Pharmacy Practice

Search results